Just one-third of medicines for rare diseases licensed for patients in Europe are available in Ireland, according to new figures released on Rare Disease Day by […]
The Irish Pharmaceutical Healthcare Association (IPHA) has defended the industry against a charge of ‘predatory’ pricing by the National Centre for Pharmoeconomics (NCPE). The NCPE is the […]
The Government has recognised the industry for “very significant work” in planning for Brexit. At the Oireachtas Committee on Health on Wednesday, the Secretary General of […]
Lawmakers in Brussels are on track towards weakening the environment for the discovery and adoption of medical innovation, potentially putting at risk the development of new […]
Two-thirds of people feel it is ‘unacceptable’ that life-changing medicines are available to patients in other countries before our own can get them, according to a […]
With the Brexit clock ticking down, IPHA has hosted a roundtable to outline the steps the industry is taking to to minimise any potential disruption to […]